Exjade

In the US, Exjade (deferasirox systemic) is a member of the drug class chelating agents and is used to treat Hemosiderosis.

US matches:

• Exjade

UK matches:

• EXJADE 125 mg, 250mg, 500mg dispersible tablets
• EXJADE 125 mg, 250mg, 500mg dispersible tablets (SPC)

Ingredient matches for Exjade

Deferasirox

Deferasirox is reported as an ingredient of Exjade in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Bulgaria


• Canada


• Croatia (Hrvatska)


• Denmark


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Indonesia


• Ireland


• Israel


• Italy


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.